Presentation of Progressive Familial Intrahepatic Cholestasis Type 3 Mimicking Wilson Disease: Molecular Genetic Diagnosis and Response to Treatment
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Progressive familial intrahepatic cholestasis type 3 (PFIC3) is an autosomal recessive disorder of cholestasis of hepatocellular origin, typically seen in infancy or childhood caused by a defect in the ABCB4 located on chromosome 7. Here we report on an older patient, aged 15, who presented with biochemical testing that led to an initial consid-eration of a diagnosis of Wilson disease (WD) resulting in a delayed diagnosis of PFIC3. Diagnosis of PFIC3 was later confirmed by molecular studies that identified novel mutations in the ABCB4 gene. Cholestasis due to PFIC3 can cause elevated hepatic copper and increased urine copper excretion that overlap with current diagnostic criteria for WD. Molecular diagnostics are very useful for establishing the diagnosis of PFIC3. Ursodeoxycholic acid amelio-rates cholestasis in PFIC3, and may help mediate a reduction in hepatic copper content in response to treatment.
Abstract
Progressive familial intrahepatic cholestasis type 3 (PFIC3) is an autosomal recessive disorder of cholestasis of hepatocellular origin, typically seen in infancy or childhood caused by a defect in the ABCB4 located on chromosome 7. Here we report on an older patient, aged 15, who presented with biochemical testing that led to an initial consid-eration of a diagnosis of Wilson disease (WD) resulting in a delayed diagnosis of PFIC3. Diagnosis of PFIC3 was later confirmed by molecular studies that identified novel mutations in the ABCB4 gene. Cholestasis due to PFIC3 can cause elevated hepatic copper and increased urine copper excretion that overlap with current diagnostic criteria for WD. Molecular diagnostics are very useful for establishing the diagnosis of PFIC3. Ursodeoxycholic acid amelio-rates cholestasis in PFIC3, and may help mediate a reduction in hepatic copper content in response to treatment.
참고문헌 (13)
- Jacquemin E, "Progressive familial intrahepatic cholestasis. Genetic basis and treatment", Clin Liver Dis, 4, pp.753~763 (2000)
- Jacquemin E, "Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases", Semin Liver Dis, 21, pp.551~562 (2001)
- Baussan C, "Genetic cholestatic liver diseases: the example of progressive familial intrahepatic cholestasis and related disorders", Acta Gastroenterol Belg, 67, pp.179~183 (2004)
- Shneider BL, "ABCB4 disease presenting with cirrhosis and copper overload-potential confusion with Wilson disease", J Clin Exp Hepatol, 1, pp.115~117 (2011)
- Ramraj R, "Progressive familial intrahepatic cholestasis type 3: overlapping presentation with Wilson disease", Clin Pediatr (Phila), 51, pp.689~691 (2012)
- European Association for Study of Liver, "EASL Clinical Practice Guidelines: Wilson's disease", J Hepatol, 56, pp.671~685 (2012)
- Sternlieb I, "Biliary proteins and ductular ultrastructure", Hepatology, 5, pp.139~143 (1985)
- Wendum D, "Aspects of liver pathology in adult patients with MDR3", ABCB4 gene mutations, 2012, pp.460, 291~298
- Sannier A, "MDR3 immunostaining on frozen liver biopsy samples is not a sensitive diagnostic tool for the detection of heterozygous MDR3", ABCB4 gene mutations, 2012, pp.460, 535~537
- Jacquemin E, "Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis", Hepatology, 25, pp.519~523 (1997)
- Davit-Spraul A, "Progressive familial intrahepatic cholestasis", Orphanet J Rare Dis, 4, pp.1~ (2009)
- Lai J, "Cholangiolocellular carcinoma in a pediatric patient with small duct sclerosing cholangitis: a case report", Semin Liver Dis, 32, pp.360~366 (2012)
- Jacquemin E, "The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood", Gastroenterology, 120, pp.1448~1458 (2001)